__timestamp | Grifols, S.A. | Lantheus Holdings, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 1699214000 | 125519000 |
Thursday, January 1, 2015 | 1930998000 | 135522000 |
Friday, January 1, 2016 | 1912291000 | 137780000 |
Sunday, January 1, 2017 | 2152011000 | 162135000 |
Monday, January 1, 2018 | 2049560000 | 174885000 |
Tuesday, January 1, 2019 | 2341232000 | 174811000 |
Wednesday, January 1, 2020 | 2255165000 | 138761000 |
Friday, January 1, 2021 | 1962596000 | 187695000 |
Saturday, January 1, 2022 | 2231530000 | 581703000 |
Sunday, January 1, 2023 | 2322701000 | 709543000 |
In pursuit of knowledge
In the ever-evolving landscape of the healthcare industry, Lantheus Holdings, Inc. and Grifols, S.A. have emerged as significant players. Over the past decade, Grifols has consistently demonstrated robust financial performance, with its gross profit peaking at approximately 2.34 billion in 2019. This represents a remarkable 38% increase from 2014. Meanwhile, Lantheus Holdings has shown impressive growth, particularly in recent years. From 2014 to 2023, Lantheus's gross profit surged by over 460%, reaching a high of 709 million in 2023. This growth trajectory highlights Lantheus's strategic advancements and market adaptability. The data underscores the dynamic nature of the healthcare sector, where innovation and strategic positioning are key to financial success. As we look to the future, these trends offer valuable insights into the competitive landscape and potential investment opportunities.
AstraZeneca PLC vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Lantheus Holdings, Inc.
Key Insights on Gross Profit: Zoetis Inc. vs Grifols, S.A.
Takeda Pharmaceutical Company Limited vs Grifols, S.A.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Teva Pharmaceutical Industries Limited or Grifols, S.A.
Who Generates Higher Gross Profit? Biogen Inc. or Grifols, S.A.
Gross Profit Trends Compared: Ascendis Pharma A/S vs Grifols, S.A.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Grifols, S.A.
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Grifols, S.A.
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Trends Compared: Grifols, S.A. vs BioCryst Pharmaceuticals, Inc.
Grifols, S.A. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis